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Introduction
T cells experience a broad range of O 2 tension in vivo, varying from 13% in peripheral arterial blood (1) to 5% in normal tissues with increased distance from blood vessels (2) , to less than 2% in chronically inflamed tissues (3) and solid tumor microenvironments (4) . Local O 2 tension is an environmental factor that affects T cell function (5, 6) . In particular, low O 2 tension (1% O 2 ; hypoxia) impairs the proliferation of human peripheral blood T cells in vitro and the activation of mouse splenic T cells in vivo (7, 8) . However, the inhibitory effects that hypoxia is thought to have on T cells are inconsistent with the robust expansion of T cells in many hypoxic inflammatory sites (9) (10) (11) . Recent studies demonstrate that hypoxia-related pathways can facilitate the differentiation of CD8 + cytotoxic T lymphocytes (CTLs) (12) and clearance of chronic viral infection and tumors (13) . These new findings suggest that low O 2 tension in tissues can be inhibitory for certain T cell subsets, but stimulatory for other T cell subsets that must be functional in hypoxic inflamed or neoplastic tissues. For instance, circulating T cells and those located in secondary lymphoid organs are mainly naive cells (T N ) and central memory T cells (T CM ), while T cells in peripheral tissues in pathologic conditions such as inflammation or tumors are predominantly effector memory T cells (T EM ) and effector T cells (T E ) (14) . Whether the low O 2 tension has distinct effects on T cell memory subsets that are differentially located within tissues remains unknown.
Hypoxia-inducible factors (HIFs) are transcription factors that facilitate cellular responses to hypoxia. HIFs are heterodimeric proteins consisting of α (HIF1α, HIF2α, and HIF3α) and β (HIF1β) subunits. While the β subunit is constitutively expressed, the α subunits are dynamically regulated by various mechanisms (2) . In normoxia, the α subunits undergo O 2 -dependent hydroxylation and proteosomal degradation via the E3 ligase von Hippel Lindau (VHL) complex (15) . By contrast, α subunits are stabilized under conditions of low O 2 tension (15) or genetic deletion of VHL (13) . In T cells, HIF1α expression is also induced both transcriptionally and translationally by T cell receptor (TCR) stimulation (16, 17) , which drives glycolytic metabolism by transcriptionally activating enzymes involved in glycolysis (12, 18) . Increased glycolysis mediated by HIF1 resembles the "metabolic switch" occurring during T cell activation (17, 19) : while resting T cells primarily use oxidative phosphorylation (OXPHOS) to generate ATP, activated T cells reprogram the metabolism to favor glycolysis to fulfill the bioenergetic and biosynthetic requirement for rapid proliferation, even when oxygen is available for OXPHOS (17) . Because the HIF1 pathway is active during T cell stimulation (13, 17, 18) , the hypoxia/ HIF1-facilitated glycolysis may converge in activated T cells with endogenous glycolytic induction to synergistically support the proliferative and effector functions.
Hypoxia occurs in many pathological conditions, including chronic inflammation and tumors, and is considered to be an inhibitor of T cell function. However, robust T cell responses occur at many hypoxic inflammatory sites, suggesting that functions of some subsets are stimulated under low oxygen conditions. Here, we investigated how hypoxic conditions influence human T cell functions and found that, in contrast to naive and central memory T cells (T N and T CM ), hypoxia enhances the proliferation, viability, and cytotoxic action of effector memory T cells (T EM ). Enhanced TEM expansion in hypoxia corresponded to high hypoxia-inducible factor 1α (HIF1α) expression and glycolytic activity compared with that observed in T N and T CM . We determined that the glycolytic enzyme GAPDH negatively regulates HIF1A expression by binding to adenylate-uridylate-rich elements in the 3′-UTR region of HIF1A mRNA in glycolytically inactive T N and T CM . Conversely, active glycolysis with decreased GAPDH availability in T EM resulted in elevated HIF1α expression. Furthermore, GAPDH overexpression reduced HIF1α expression and impaired proliferation and survival of T cells in hypoxia, indicating that high glycolytic metabolism drives increases in HIF1α to enhance T EM function during hypoxia. This work demonstrates that glycolytic metabolism regulates the translation of HIF1A to determine T cell responses to hypoxia and implicates GAPDH as a potential mechanism for controlling T cell function in peripheral tissue.
Glycolysis determines dichotomous regulation of T cell subsets in hypoxia cells (62.8% ± 3.1% vs. 12.4% ± 2.5% in PB-Ts) and were phenotypically similar to the T EM detected in PB-Ts, based on various T cell differentiation markers (CD25, CD27, CD28, CD45RO, and CD62L) (Supplemental Figure 2) . We activated T EXP with OKT3/a-CD28 Abs under hypoxic or normoxic conditions and measured proliferation and cell viability 72 hours after stimulation. In sharp contrast to unselected PB-Ts, cell counts of T EXP were higher in hypoxia than in normoxia ( Figure 1A ) as a result of both enhanced cell division ( Figure 1 , B-D) and reduced cell apoptosis ( Figure 1E ). In hypoxia, T EXP showed lower expression of the death receptor CD95/Fas (Figure 1 , F and G) and reduced caspase activity (Figure 1H) , which further suggests a reduced potential for induction of apoptosis. In addition, mRNA expression of the antiapoptotic genes BCL2 and BNIP3 was significantly higher in T EXP activated in hypoxia, while the expression of FAS mRNA decreased (Supplemental Figure 3 ), correlating with the reduced apoptosis of T EXP in hypoxia. T EXP showed a comparable percentage of CD4 + and CD8 + T cells when activated in hypoxia or normoxia (Supplemental Figure 4A ). Furthermore, both CD4 + and CD8 + T EXP disHere, we show that T EM have immediate superior proliferation and effector function under hypoxic conditions, while T N and T CM are inhibited under these conditions. This distinct pattern of hypoxia response is attributed to the differential expression of HIF1α and related glycolytic activity in T cell memory subsets. Furthermore, the differential HIF1α expression is linked to a novel mechanism of translational regulation by the glycolytic enzyme GAPDH in T cells.
Results

Proliferation and survival of human T EM are enhanced in hypoxia.
Previous studies have suggested an inhibitory role of hypoxia in activated human T cells (20) . We confirmed that freshly isolated peripheral blood T cells (PB-Ts) have impaired proliferation and viability upon activation with OKT3/a-CD28 Abs in hypoxia (1% O 2 ) as compared with that observed in normoxia (20% O 2 ) (Supplemental cell division. Collectively, these data indicate that T EXP and T EM are intrinsically equipped to positively respond to hypoxia, a finding that functionally distinguishes them from T N and T CM .
Cytotoxic function of tumor-specific T EXP is enhanced by hypoxia. Because hypoxia positively regulates the proliferation and survival of T EM , we speculated that hypoxia might also modulate their cytotoxic function. To confer antigen specificity to T EM , we transduced activated human T cells with a retroviral vector encoding a GD2-specific chimeric antigen receptor (CAR.GD2-T) (23) and cocultured CAR.GD2-T with GD2 + neuroblastoma tumor cells (LA-N-1) in normoxia or hypoxia for 48 hours. Fewer tumor cells survived when cocultured with CAR.GD2-T in hypoxia than occurred in normoxia. That this was a result of cytotoxicity rather than impaired tumor cell growth in hypoxic conditions was illustrated by coculture of tumor cells with nontransduced T cells (NTs), in which a similar percentage and number of surviving tumor cells were observed in both hypoxic and normoxic conditions at the end of the experiment ( Figure 3, A and B) . Although T EXP showed enhanced cell expansion in hypoxia at 72 hours upon OKT3/a-CD28 stimulation, after 48 hours of coculture, the number of CAR.GD2-T was similar in hypoxic and normoxic conditions ( Figure 3C ). To determine whether the observed enhanced antitumor activity in hypoxia is due to altered tumor cell susceptibility to the cytotoxic activity of CAR.GD2-T, we used LA-N-1 cells cultured in hypoxia or normoxia as target cells in cytotoxicity assays performed in normoxia. LA-N-1 cells cultured in hypoxia did not show increased susceptibility to lysis by CAR.GD2-T compared with that observed with LA-N-1 cells growing in normoxic conditions ( Figure 3D ). In addition, we observed a similar CD4/CD8 composition of CAR.
played enhanced proliferation and survival in hypoxia compared with that observed in normoxia (Supplemental Figure 4 , B-D). These results suggest that the dichotomous influence of hypoxia on PB-Ts versus that on T EXP was not due to the disparities in CD4 and CD8 composition. Finally, hypoxia did not affect the production of IL-2, IFN-γ, or TNF-α, nor did it affect the expression of the IL-2 receptor CD25 or the early T cell activation marker CD69 (Supplemental Figure 4 , E and F). Overall, these data suggest that T EXP show a unique pattern of response upon activation in hypoxia.
Because T EXP are generated through ex vivo culture, which may alter the native characteristics of these cells, even if they are phenotypically similar to the T EM detected in the PB-Ts, we sorted T N , T CM , and T EM from PB-Ts on the basis of the expression of CD45RA and CCR7 (Supplemental (Figure 2 , A-C), which is likely to account for the observed overall inhibition of proliferation of unselected PB-Ts (Supplemental Figure 1) . Notably, while CD95/Fas expression in T N and T CM was comparable under hypoxic and normoxic conditions, the level of expression in these subsets was 2-to 3-fold lower than that detected in T EM ( Figure 2F ), which is consistent with the reduced susceptibility of T N and T CM to Fas-mediated apoptosis (22) . Hence, the reduced expansion of T N and T CM in hypoxia is likely due to reduced Tumor-related hypoxia promotes the cycling of tumor-specific T EXP in vivo. Solid tumors are well recognized as hypoxic tissues, with O 2 tension ranging from 0% to 4%, depending on the distance from the blood vessel (4, 24, 25) . Previous studies have indicated that tumor-infiltrating T cells are present in both O 2 -rich and O 2 -poor areas of tumor (26, 27) . We thus used xenograft tumor models to determine whether low O 2 tension within the tumor affects the proliferation of T EM in vivo. We engrafted NOD/SCID/γ c -/-(NSG) mice s.c. with neuroblastoma tumor cells. After engraftment, we intratumorally inoculated the mice with CAR.GD2-T or control T EXP expressing a nontumor-targeting CAR specific for the CD19 antigen (CAR.CD19-T) ( Figure 4A Cr release assay (Supplemental Figure 6B) . Collectively, these data suggest an increase in the per-cell cytotoxicity of CAR.GD2-T cells in hypoxia.
Unlike mouse CD8 + CTLs, which express increased levels of lytic enzymes in hypoxia (12, 13) , the expression of perforin and granzyme B in activated human CAR.GD2-T remained unchanged in hypoxia ( Figure 3E ). However, the superior antitumor activity of CAR.GD2-T in hypoxia correlated with enhanced degranulation of CD8 + CAR.GD2-T upon specific CAR.GD2 activation ( Figure  3F ). Stimulation of CAR.GD2-T in hypoxia with OKT3/a-CD28 Abs also induced more degranulation ( Figure 3G ), indicating that the enhanced degranulation in hypoxia is not due to an intrinsic property of the CAR.GD2 molecule but is recapitulated upon TCR stimulation. Collectively, our data indicate that the cytotoxic function of T EXP is enhanced under hypoxic conditions. or gene transfer. We found that HIF1α was required and sufficient for promoting the proliferation of T EXP (Supplemental Figure 7 , A-F), which highlights the critical role of HIF1α in T EXP under hypoxic conditions. Previous studies have also hinted at a role of HIF2α in regulating T E functions (13). Though we found that EPAS1 (which encodes for HIF2α) mRNA expression was higher in T EXP cells than in PB-Ts, it was expressed at very low levels in both cell types (10 -6 -fold expression compared with ACTB mRNA) (Supplemental Figure 7G) , and we were unable to detect HIF2α protein expression in either T EXP or PB-Ts by Western blotting (data not shown). Thus, we focused our study on HIF1α expression for subsequent analysis.
HIF1α accumulates in normal cells in hypoxia but is also constitutively overexpressed in some tumor cells in normoxia (25, 30) , which facilitates aerobic glycolytic metabolism (the Warburg effect) (25) . We postulated that HIF1α may also be overexpressed in T EXP and facilitate their metabolism and survival in hypoxia. Accordingly, we found that while HIF1α accumulated in PB-Ts after antigen stimulation in hypoxia, T EXP showed detectable (HP1 -). This effect was antigen specific, as CAR.CD19-T showed minimal proliferation in both HP1 + and HP1 -areas ( Figure 4 , C and D). Of note, the percentages of CD4 + and CD8 + CAR.GD2-T were comparable in HP1 -and HP1 + areas ( Figure 4E ), suggesting that there is no preferential localization or expansion of either population in hypoxic tumor areas. In a second tumor model in which mice were engrafted s.c. with CD19 + lymphoma cells and then infused i.v. with CAR.CD19-T, we also found that the CAR.CD19-T that reached hypoxic tumor areas were more proliferative than those that reached normoxic tumor areas (Figure 4, F and G) . Collectively, these in vivo experiments indicate that hypoxia enhances the proliferation of antigen-specific CAR-T.
T EXP display elevated HIF1α expression and glycolytic activity. HIF1 is a critical transcriptional factor that facilitates cellular adaptation to hypoxia (2, 30) . To assess whether HIF1 plays a role in T EXP function within our experimental model, we blocked its activity with the HIF1α inhibitor BAY87-2243 (31) HIF1α expression in hypoxia without TCR/CD28 stimulation, and expression increased after stimulation in either hypoxia or normoxia ( Figure 5A ). Since we could not acquire a sufficient number of freshly isolated T EM for immunoblot analysis via FACS sorting (Supplemental Figure 5) , we compared HIF1α expression in FACSsorted T N , T CM , and T EM by quantitating intracellular HIF1α staining and flow cytometry. Using this approach, HIF1α protein expression dynamics mirrored the responses to the hypoxia and antigen receptor stimulation observed in T EXP (Supplemental Figure 8, A and B) . We thus applied our staining protocol to FACS-sorted T N , T CM , and T EM subsets. Notably, HIF1α only accumulated after activation in hypoxia in T N and T CM (Supplemental Figure 8, C and D) , while T EM showed elevated HIF1α expression in hypoxia without stimulation, which was further increased after activation, as observed in T EXP (Supplemental Figure 8, C and D) . These data suggest that the differential HIF1α expression in T EXP and PB-Ts represents a bona fide difference between T N /T CM and T EM subsets. Consistent with HIF1α expression, the HIF1-targeted glycolytic genes GLUT1 and LDHA were expressed at higher levels in T EXP compared with levels detected in PB-Ts ( Figure 5 , B and C). The higher expression of these genes in T EXP was associated with more glucose uptake ( Figure 5D ) and lactate secretion ( Figure 5E) . Notably, the glycolytic activity in unstimulated T EXP was almost comparable to that of activated PB-Ts, suggesting that T EM are imprinted to preferentially Figure 5 . T EXP display elevated HIF1α expression and glycolytic activity. (A) HIF1α protein expression in PB-Ts and T EXP that were unstimulated or stimulated with OKT3/a-CD28 Abs in normoxia or hypoxia for 24 hours. . n = 3. Blot images were acquired from samples run on parallel gels. (B and C) Expression of HIF1α target genes LDHA and GLUT1 either as mRNA (B) or protein (C) in PB-Ts and T EXP that were unstimulated (No stim) or stimulated with OKT3/a-CD28 Abs in normoxia or hypoxia for 24 hours. Transcript expression was normalized against the housekeeping control 18S RNA and then standardized to 1.0 in unstimulated PB-Ts. n = 3. *P < 0.05 and ****P < 0.0001, 2-way ANOVA with Bonferroni's post-hoc analysis. (D) Glucose uptake in PB-Ts and T EXP that were unstimulated or stimulated with OKT3/a-CD28 Abs in hypoxia for 72 hours. n = 3. **P = 0.0021 for unstimulated PB-Ts versus unstimulated T EXP and **P = 0.0024 for stimulated PB-Ts versus stimulated T EXP , 2-way ANOVA with Bonferroni's post-hoc analysis. (E) Lactate secretion by unstimulated PB-Ts and T EXP in normoxia and hypoxia for 6 hours. n = 3. *P = 0.018 and ***P = 0.0003, 2-way ANOVA with Bonferroni's post-hoc analysis. (F-H) T EXP were untreated (No Tx) or exposed to 1 mM 2-DG or 50 nM oligomycin (Oligo) after stimulation with OKT3/a-CD28 Abs in normoxia or hypoxia. Cell counts (F) and cell viability (G) were determined 72 hours after activation. n = 13 for untreated and 2-DG, and n = 5 for oligomycin. ****P < 0.0001, 2-way ANOVA with Bonferroni's post-hoc analysis. (H) CellTrace Violet dilution of labeled T EXP 72 hours after stimulation. n = 6. Error bars indicate SD. jci.org Volume 126 Number 7 July 2016 use glucose metabolism that is similar to that of activated T N (17) . The high glycolytic activity of T EXP is critical for their functionality in hypoxia, given that partial inhibition of glycolysis in T EXP using low doses of the competitive glycolytic inhibitor 2-deoxyglucose (2-DG) was sufficient to abolish the enhanced viability and proliferation of T EXP in hypoxia ( Figure 5 , F-H, and Supplemental Figure 9 , A-C). The mitochondrial inhibitor oligomycin, however, did not affect the proliferation or survival of T EXP in either normoxic or hypoxic conditions, which suggests that, like tumor cells (25) , T EXP may have intrinsically lower or dispensable mitochondrial functions that allow them to overcome the severe impairment in hypoxia of ATP synthesis from OXPHOS. In contrast, oligomycin suppressed the expansion and viability of PB-Ts in normoxia but did not contribute synergistically to the inhibitory effects of hypoxia (Supplemental Figure 9 , D-F). These latter observations suggest that the reduction of PB-T proliferation and survival in hypoxia may be attributed to a mechanism related to the inhibition of mitochondrial function. In summary, our data demonstrate that T EXP express high levels of HIF1α and display a glycolysiscentric metabolism, which is critical for their functionality in hypoxia.
Differential expression of HIF1α in T cell memory subsets is translationally regulated by GAPDH.
To mechanistically explain the distinct hypoxia response patterns in T cell memory subsets, we investigated the molecular programs that regulate HIF1α expression in both T EXP and PB-Ts. The steady-state expression of the mRNA transcript encoding HIF1α was comparable between unstimulated T EXP and PB-Ts and was similarly induced after T cell activation (Supplemental Figure 10A ). These results excluded a primarily transcriptional regulatory mechanism underling the differential relative expression of HIF1α protein in these 2 populations of cells. Inhibition of proteasomal degradation did not normalize HIF1α protein expression in T EXP or PB-Ts and only minimally increased HIF1α levels in unstimulated PB-Ts, as measured by quantitative HIF1α ELISA (Supplemental Figure 10B ), suggesting that differential proteasome degradation is not sufficient to explain the observed differences in HIF1α protein expression in PB-Ts and T EXP . Together, these data suggest the possibility that translation of the HIF1A mRNA transcript might be inhibited in PB-Ts. Because the translation of HIF1A in T cells is facilitated by IL-2 signaling and the PI3K/mTOR pathway (12, 33) , we evaluated the phosphorylation status of mTOR and its effector S6 kinase in both normoxia and hypoxia in T EXP and PB-Ts, but did not find a significant difference (Supplemental Figure 10C) .
Messenger RNAs containing cis-acting adenylate-uridylate-rich elements (AREs) in their 3′-UTRs are often targets of RNA-binding proteins that regulate their stability (34, 35) . In situ analysis revealed elevated proliferation, survival, and cytotoxic activity. Therefore, hypoxia may serve as both a tolerance mechanism for T N and T CM in secondary lymphoid organs by preventing excessive proliferation and a license mechanism for T EM in inflamed or malignant tissues by facilitating proliferation and effector functions. T N , T CM , and T EM have highly specified functional distinctions, and thus it is intuitive that low O 2 supply may be perceived differently by these subsets. In particular, the assumption that hypoxia impairs T-cell-mediated immune responses (40, 41) does not take into account the fact that hypoxia is present in almost all pathological conditions in which immune cells must execute essential protective functions. We have found that T EM , but not T N or T CM , react to low O 2 supply by proliferating. Of note, although T EM have a proliferative potential inferior to that of T N and T CM upon stimulation in normoxia (14) , this deficiency is corrected in hypoxia, in which T EM divisions are almost comparable to those of T N and T CM in normoxia. These findings suggest that T EM are not intrinsically restricted in their proliferative capacity compared with T N or T CM but require additional environmental input to fully exploit it. Alternatively, the O 2 -rich condition may pose an inhibitory effect on T EM , possibly through the generation of ROS, which is relieved in hypoxia (25, 42) . Further studies are needed to elucidate these mechanisms.
The enhanced functions of T EM in hypoxia correspond to a "hypoxia adaptation signature" with higher expression of the master hypoxia transcriptional regulator HIF1α and increased activity and dependency of aerobic glycolysis in T EM compared with that in T N and T CM . T EM are insensitive to mitochondrial inhibition, while a reduction of glycolytic activity abrogates their functional advantage in hypoxia. Of note, neutrophils and macrophages, which are immune cells specialized to function within hypoxic inflammatory sites, show similar glycolysis-dominant metabolic profiles (6, 43) , suggesting that the observed hypoxia adaptation signature in T EM may represent an evolutionarily conserved pathway for cells that function in low-O 2 conditions. This is further supported by findings in cancer cells that exclusively rely on aerobic glycolysis for their growth (25) and the overexpression of HIF1α in many solid tumors, even in the absence of related genetic mutations (2, 30) .
How and whether HIF1α contributes to the regulation of T cell responses remains controversial. Earlier studies demonstrated that targeted deletion of HIF1α in T cells enhanced their proliferation and antibacterial responses, suggesting a negative regulatory function of HIF1α in T cells that might protect tissues from immune damage (41) . In contrast, recent findings suggest that HIF1α is critical for the differentiation and function of T E (12, 13) . These discrepancies can be attributed to differences in infection models and uncharacterized roles of HIF1α during the development of T cells in HIF1α-deleted mice. Our data in human T cells are consistent with those from more recent studies in mice showing that HIF1α and hypoxia promote T EM functions (12, 13) . This functional correlation is further supported by the mechanistic link we have identified between HIF1α expression and glycolysis. We discovered that HIF1α can be regulated at the translational level by the glycolytic enzyme GAPDH. In T N and T CM , GAPDH is disengaged from the glycolytic pathway, since these cells are characterized by low glycolytic activity, and GAPDH can bind to the AREs in the 3′-UTR of HIF1A mRNA, suppressing its translation. In contrast, GAPDH binding is absent in T EM , which have enhanced glycolytic 7 "AUUUA" pentamer AREs and 3 "UUAUUUAUU" nonamer AREs within the HIF1A 3′-UTR (Supplemental Figure 11A) . Many of these AREs are highly evolutionarily conserved among different species (3′-UTR analyzed using the AREsite database; http://nibiru.tbi.univie. ac.at/AREsite2/welcome) (36) , suggesting that these elements may be pivotal in HIF1A mRNA regulation. We thus performed a 3′-UTRbased reporter assay to determine whether the HIF1A 3′-UTR alone is adequate to confer translational regulation in T cells. The HIF1A 3′-UTR specifically reduced the reporter expression in PB-Ts but not in T EXP ( Figure 6A) . Notably, the reduction in reporter expression by HIF1A 3′-UTR in PB-Ts was partially reverted when the AREs were mutated. These data suggest a specific translational regulation of HIF1A mRNA mediated by the AREs in its 3′-UTR in PB-Ts, but not in T EXP . Importantly, we found that the insensitivity to translational suppression by the HIF1A 3′-UTR of T EXP may be attributed to their high glycolytic activity. T EXP with dampened glycolysis by 2-DG showed reduced reporter expression with the HIF1A 3′-UTR compared with control 3′-UTR or the HIF1A 3′-UTR ARE mutant (Supplemental Figure 11B) . These data suggest a link between the regulation of HIF1α expression via its 3′-UTR and glycolytic status in T cells.
The glycolytic enzyme GAPDH can function as an RNA-binding protein (37, 38) and can negatively regulate the translation of IL-2 and IFN-γ in activated T cells via specific binding to AREs within the mRNAs encoding these gene products (38, 39) . Notably, this translational regulation only occurs in T cells with low glycolytic activity when GAPDH is not engaged in its main function as a glycolytic enzyme (39) . Thus, we tested whether GAPDH may also act as a suppressor for HIF1A mRNA translation, preferentially in PB-Ts that have less active glycolysis as compared with T EXP that have high glycolytic activity. We performed RNA IP assays using GAPDH Ab and found a greater than 5-fold enrichment of HIF1A mRNA in the α-GAPDH Ab immunoprecipitate compared with the IgG control immunoprecipitate in PB-Ts ( Figure 6B ). In contrast, no enrichment of HIF1A mRNA was observed in T EXP . Furthermore, we did not find enrichment of β-actin (ACTB) mRNA in either T EXP or PB-Ts, suggesting that the binding of GAPDH to HIF1A mRNA is specific.
To further demonstrate the critical role of GAPDH in suppressing HIF1α protein expression, we overexpressed GAPDH in T EXP (Supplemental Figure 12 , A and B) and found that HIF1α protein, but not mRNA, expression was reduced ( Figure 6C , Supplemental Figure 12C ). Reduction of HIF1α in T EXP by GAPDH overexpression did not impair the differentiation of T EXP (Supplemental Figure  12D ), but caused a reduction of the glycolytic activity, cell expansion, survival, and proliferation of T EXP in hypoxia ( Figure 6D and Supplemental Figure 12 , E and F). Notably, using the in vivo model we developed (shown in Figure 4 ), we found that CAR.GD2-T in which we overexpressed GAPDH showed significantly reduced proliferation in hypoxic tumor areas compared with that seen in mock CAR.GD2-T (Supplemental Figure 12G) . GAPDH is thus a novel regulator for HIF1A mRNA translation and links HIF1α protein expression to the glycolytic activity in T cell memory subsets.
Discussion
T cell activation relies not only on TCR and costimulatory signals but also on environmental inputs including O 2 availability. Here, we demonstrate dichotomous roles of hypoxia on human T cell subsets. Specifically, while T N and T CM are suppressed in hypoxia, T EM show jci.org Volume 126 Number 7 July 2016
Isolation of human peripheral blood T cells and expansion of T EM Human PBMCs were obtained from healthy volunteer donors (Gulf Coast Regional Blood Center) by Ficoll, and peripheral blood T cells were isolated by magnetic sorting using a pan-T cell selection kit from Miltenyi Biotec. T EM were expanded by stimulation with plate-bound OKT3 (1 ng/ml) and CD28 Abs (BD Biosciences) and then cultured in media containing 45% Click's media (Irvine Scientific); 45% RPMI 1640 (HyClone); 10% FBS (HyClone); 1% L-glutamine (Invitrogen); and 100 U/ml IL-2 (Teceleukin) for 10 to 12 days. For CAR-modified T EM , stimulated PBMCs were transduced with a γ retroviral vector encoding a second-generation (CD28) CAR targeting the GD2 antigen (CAR.GD2) and maintained in 50 U/ml IL-2 for 10 days. (effector memory) subsets were then sorted by FACS. The purity of sorted subsets was greater than 95%.
Cell sorting
In vitro hypoxia incubation
Most of the hypoxia experiments were conducted using the hypoxia incubator (Thermo Scientific). For protein analysis and other timesensitive experiments, a hypoxia glove box (Coy Lab Products) was used so that protein extraction was performed under hypoxic conditions. To activate T cells in hypoxia, cells were preincubated in hypoxia (1% O 2 ) for 24 hours and activated with plate-bound OKT3/a-CD28 Abs. Anti-CAR.GD2 Ab 1A7 was used to activate CAR.GD2-T cells. After 6 hours of incubation in normoxia or hypoxia, the supernatant was harvested from each well, and chromium release was measured in a gamma counter (PerkinElmer). For each target, spontaneous and maximum release were used to calculate the percentage of specific release, according to the following formula: (experimental cpm -spontaneous cpm) / (maximum cpm -spontaneous cpm).
Flow cytometry
activity, and GAPDH is fully engaged in glycolysis. This role of GAPDH mimics the mechanism that was previously observed for IFNG mRNA, which is also regulated at the translational level by GAPDH in a glycolysis-related manner (39) . Unfortunately, we could not perform RNA IP experiments using freshly isolated T EM because of the scarceness of this subset in the peripheral blood, and thus we cannot formally prove that GAPDH binds to HIF1A mRNA in T EM . Although we also acknowledge that T EXP cannot be considered identical to T EM freshly isolated from the peripheral blood, we showed that both T EM and T EXP have similar upregulation of HIF1α protein expression and phenotypic behavior in hypoxia. It is also likely that additional mechanisms may also contribute to the enhanced expression of HIF1α in T EM . Our findings also suggest a positive feedback loop between HIF1α expression and glycolysis in T cells. While the inhibition of HIF1α expression by GAPDH is relieved upon the elevation of glycolytic activity, HIF1 transactivates its target genes that further facilitate glycolysis. When and how this loop is initiated during T cell differentiation remains to be investigated. Previous studies showed that Myc mediates a glycolytic switch upon activation in T N (17) . It is thus possible that the effect of Myc is still persisting in T cells differentiating in culture upon stimulation and this could partially explain the glycolytic activity of T EXP in steady-state conditions under normoxia. We believe our experiments using adoptively transferred tumor-specific T cells also provide significant insight to the field of cancer immunotherapy. The microenvironment in solid tumors is hypoxic due to dysfunctional angiogenesis (4, 25) . The "hypoxia adaptation signature" we found in T EM can be potentially exploited through genetic manipulations in subsets of tumor-specific T cells to enhance their functions in hypoxic tumor sites. On the other hand, the tumor microenvironment is also deprived of glucose and other nutrients because of the high metabolic rate of tumor cells (44) . T cells must compete with tumor cells for glucose to support their effector functions and proliferation in hypoxia, and T cells in metabolite-restricted conditions express high levels of the inhibitory receptor programmed death 1 (PD1) and produce less IFN-γ upon activation (39); thus, strategies aimed at enhancing the capacity of T cells to compete for glucose may enhance their antitumor effects.
Overall, we believe our findings redefine the role of hypoxia in regulating T cell responses, especially in pathological peripheral tissues. The translational regulation of HIF1α by the glycolytic enzyme GAPDH represents a novel mechanism in the control of T cell functions via cellular metabolism.
Methods
Cell line
The CHLA-255 neuroblastoma cell line was provided by L.S. Metelitsa of Baylor College of Medicine (45) and was maintained in IMDM (Gibco) supplemented with 10% FBS (HyClone) and 2 mM Glutamax (Invitrogen). The LA-N-1 neuroblastoma cell line was obtained from M. Brenner at Baylor College of Medicine. The LA-N-1 cell line and EBV-transformed lymphoblastoid cell lines (LCLs) were cultured in RPMI 1640 (HyClone) supplemented with 10% FBS (HyClone) and 2 mM Glutamax (Invitrogen). All cell lines were routinely tested for mycoplasma and for surface expression of target antigens. jci.org
Volume 126 Number 7 July 2016 0.5% Nonidet P-40 detergent supplemented with fresh 1 mm DTT; 1,000 units/ml RNAsin (Promega); and Mini Protease Inhibitor Cocktail (Thermo Fisher Scientific). The post-nuclear cytosolic content was collected and removed for input samples (10%). The remaining lysates were immunoprecipitated with 10 μg anti-GAPDH Abs (Life Technologies) or with control mouse IgG Abs (The Jackson Laboratory) using a Pierce Crosslink IP Kit (Thermo Fisher Scientific). The rest of the immunoprecipitated complexes were digested with 30 μg proteinase K. The immunoprecipitates and input samples were subjected to RNA extraction using TRIzol LS Reagent (Life Technologies). RNA isolates were used for first-strand cDNA synthesis using a SuperScript VILO cDNA Synthesis Kit (Life Technologies). cDNA was used for qPCR quantification, with HIF1α or β-actin as a control. The Ct for each RNA IP sample was normalized to that of total input to account for the differences in sample preparation using the following calculation: ΔCt (normalized) = Ct (sample) -(Ct [input] -log 2 [10] ). The ΔCt (normalized) of the GAPDH IP sample was further normalized to the IgG IP sample as follows: ΔΔCt = ΔCt (normalized) GAPDH -ΔCt (normalized) IgG . The immunoprecipitation fold enrichment above the sample-specific background was calculated as follows: fold enrichment = 2 (-ΔΔCT) .
Statistics
A paired, 2-tailed Student's t test was used to determine statistically significant differences between 2 samples. When multiple comparison analyses were required, statistical significance was evaluated by ANOVA, followed by Bonferroni's post-hoc analysis. If the data reflected measurement of 1 sample over time or under different conditions, repeated-measures ANOVA was used, followed by Bonferroni's post-hoc analysis. Graph generation and statistical analyses were performed using GraphPad Prism, version 5.0d (GraphPad Software). A P value of less than 0.05 was considered statistically significant.
Study approval
The present studies in animals were reviewed and approved by the IACUCs of Baylor College of Medicine and the University of North Carolina.
